A retrospective review of comprehensive quality assurance databases of screening tests and cervical biopsy results from the Regional Laboratory of the Kaiser Permanente Northern California (KPNC ...

When treated while the cancer is still localized, the five-year survival rate is about 90%. A Pap smear is used to screen for HPV, cervical dysplasia, and cervical cancer. A biopsy is needed to ...

Among patients of child-bearing age, the crucial topic of whether cervical cancer impacts fertility frequently comes up ...

Cervical cancer screening is one of the best success stories in health care. Since the 1970s, the death rate from cervical ...

The most definitive diagnostic method of cervical cancer is a cervical biopsy. Before proceeding for cervical biopsy patients are often screened with the available tests such as pap smear ...

While screenings and vaccinations have brought down cervical cancer rates for millions of women, in some age groups, cases ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

The Trust admitted that had the sample been correctly reported as high-grade moderate or severe changes, Amie would have been ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

Cervical cancer symptoms are often absent in the early stages and may only become apparent when the disease is more advanced. Abnormal vaginal bleeding is the most common symptom overall, often ...